Efficacy and Safety of Tildrakizumab in Participants With Moderate-to-Severe Chronic Plaque Psoriasis Who Are Non-Responders to Dimethyl Fumarate Therapy
Clinical trial NCT04263610 · COMPLETED
Trial details
- NCT number
- NCT04263610
- Sponsor
- Almirall, S.A.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-04
- Primary completion
- 2022-02-16
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.